New heart drug candidate passes first safety check in healthy volunteers
Knowledge-focused
Completed
This study looked at how safe a new drug called HRS-1893 is and how the body handles it. Twenty healthy adults took a single dose by mouth. The goal was to gather basic information before testing the drug in people with hypertrophic cardiomyopathy, a heart muscle disease.
Phase: EARLY_PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 04:37 UTC